*Department of Dermatology, University of California-San Francisco, San Francisco, CA;
†Yale School of Medicine, New Haven, CT;
‡Department of Dermatology, University of Pennsylvania, Philadelphia, PA;
§Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA;
‖Department of Pathology and Laboratory Medicine, University of California-San Francisco, San Francisco, CA;
¶Infectious Disease Institute, Makerere University, Kampala, Uganda;
#Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda;
**Department of Pathology, Moi University School of Medicine, Eldoret, Kenya;
††Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya;
‡‡Department of Hematology and Oncology, Moi Teaching and Referral Hospital, Eldoret, Kenya; and
§§Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
Correspondence to: Erin Amerson, MD, Department of Dermatology, University of California-San Francisco, 1701 Divisadero Street, San Francisco, CA 94115 (e-mail: [email protected]).
Supported by National Institutes of Health (NIH) grants U01 AI069911, R01 CA119903, D43 CA 153717, U54 CA190153, and the G. D. Hsuing, PhD Student Research Fellowship at Yale University School of Medicine.
Presented in part at the 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies, November 7–8, 2011, Bethesda, MD.
The authors have no funding or conflicts of interest to disclose.
Received June 26, 2015
Accepted September 08, 2015
